Skip to content

Glucose transport and mitochondrial function in type 1 diabetes mellitus

Glucose transport and mitochondrial function in type 1 diabetes mellitus - GRACE

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON52326
Enrollment
41
Registered
2021-03-31
Start date
2021-04-30
Completion date
Unknown
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

4 weeks of moderate-intensity cycle exercise training on a cycle ergometer in the laboratory. Sessions will consist of 3 x 30 minutes exercise in week 1, 3 x 40 minutes exercise in week 2, 3 x 50 mi

Sponsors

Vrije Universiteit
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, participants with T1DM must meet all of the following criteria: • Individuals with T1DM with a diagnosed disease duration of 1 - 45 years • Male or female • Aged between 18-65 years In order to be eligible to participate in this study, healthy control participants must meet all of the following criteria: • No chronic health conditions and between the ages of 18-65

Exclusion criteria

Exclusion criteria: • History of asthma, stroke, chronic obstructive pulmonary disease, congestive heart failure, heart surgery, or congenital heart diseases • Current treatment with drugs known to interfere with metabolism e.g. systemic corticosteroids, statins, SGLT2 inhibitors, GLP1 receptor agonists • Are current smokers or have been a regular smoker within the last 12 months • Insulin pump therapy • Symptomatic autonomic or distal neuropathy • BMI >30 due to adiposity, since this is known to cause difficulties in obtaining muscle biopsies. • Pregnancy • Recent acute myocardial infarction (150 mmHg and Diastolic Blood Pressure > 100 mmHg on repeated measurements) • Active infection, anaemia, severe renal dysfunction (estimated Glomerular filtration rate 6 alcohol units per day or >14 alcohol units per week • Use of anticoagulants or anti platelet therapy

Design outcomes

Primary

MeasureTime frame
Main study parameters: The differences in markers of insulin-independent glucose uptake, parameters of mitochondrial function and exercise tolerance between T1DM and control groups both before and after the exercise training intervention.

Secondary

MeasureTime frame
Secondary Study Parameters: The differences in exercise tolerance and aerobic function parameters between T1DM and control groups before and after the exercise training intervention, and their relationships with markers of mitochondrial function.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)